Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 7 clinical trials
Featured trial
A Randomized, Double-Blind, Double-Dummy, Active-Controlled Study Comparing the Efficacy, Safety and Tolerability of ABBV-951 to Oral Carbidopa/Levodopa in Advanced Parkinson's Disease Patients

The purpose of this study is to find out how well ABBV-951 works to control Parkinson's disease symptoms compared to oral Carbidopa (CD)/Levodopa (LD). The study is also seeking to test whether ABBV-951 is well tolerated in subjects with Parkinson's disease.

carbidopa
levodopa
  • 102 views
  • 23 Nov, 2020
  • 1 location
Featured trial
A Phase III, Multicenter, Randomized, Double-Blind, Double-Dummy, Active-Controlled Study Comparing the Efficacy and Safety of Gastric Retentive, Controlled Release Accordion Pill™ Carbidopa/Levodopa (AP-CD/LD) to Immediate Release CD/LD in Fluctuating Parkinson’s Disease Patients

A Phase III, Multicenter, Randomized, Double-Blind, Double-Dummy, Active-Controlled Study Comparing the Efficacy and Safety of Gastric Retentive, Controlled Release Accordion Pill™ Carbidopa/Levodopa

  • 342 views
  • 08 Nov, 2020
  • 1 location
Featured trial
An Open-Label Trial Of Oral Selegiline 5 Or 10 Mg And Tadalafil 2.5 Mg Co-Administration To Male Patients With Parkinson's Disease And Moderate Erectile Dysfunction.

An Open-Label Trial Of Oral Selegiline 5 Or 10 Mg And Tadalafil 2.5 Mg Co-Administration To Male Patients With Parkinson's Disease And Moderate Erectile Dysfunction.

  • 895 views
  • 08 Nov, 2020
  • 2 locations
None
1/2-Dopaminergic Dysfunction in Late-Life Depression (The D3 Study)

], and behavioral / self-report); and 2) examine the responsivity of dopamine-related circuits and behavior to stimulation with carbidopa/levodopa (L-DOPA).

  • 0 views
  • 31 Mar, 2021
  • 1 location
None
L-DOPA vs. Placebo for Depression and Psychomotor Slowing in Older Adults

motor slowing. The central hypothesis of this study is that by enhancing dopamine functioning in the brain and improving cognitive and motor slowing, administration of carbidopa/levodopa (L-DOPA) will

carbidopa/levodopa
depression
psychotic
psychotherapy
depressive disorder
  • 0 views
  • 30 Apr, 2021
None
Dopaminergic Dysfunction in Late-Life Depression

carbidopa/levodopa (L-DOPA) will improve depressive symptoms.

  • 0 views
  • 24 Feb, 2021
  • 1 location
None
Social Decision Making in Parkinson's Disease

, and on-DAA visit, and an off-DAA visit. For both the on and off DAA visits, participants will continue taking Carbidopa-Levodopa, but will withdrawal off of other PD related medications. Both visits

dopamine agonists
neurodegenerative disorders
levodopa
carbidopa/levodopa
carbidopa
  • 1 views
  • 10 Oct, 2021
  • 1 location